Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Neuropharmacology. 2017 Sep 5;126:151–157. doi: 10.1016/j.neuropharm.2017.09.005

Figure 5. Systemic administration of either a DA D1 agonist or a D2 antagonist potentiates NADPH-d staining elicited in the msNAc during electrical train stimulation of the fimbria.

Figure 5

A) The increase in the intensity of NADPH-d staining induced in the msNAc during high frequency stimulation (50 Hz at 750μA, 0.5 ms, 2 s ITI for 20 minutes duration) of the fimbria was potentiated by systemic administration of either the DA D1 agonist SKF (500μg/kg, i.p.) or the DA D2 antagonist ETI (100μg/kg, i.p.) as compared to saline treated controls (*p<0.05). Results are expressed as the mean ± S.E.M. from n=5–7 rats per group.